H.C. Wainwright Reiterates Buy Rating on Halozyme Therapeutics (HALO)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/13/2026

1. CSCO
2. COHR
3. CBRS
4. STUB
5. EAT
6. SPY
7. WYFI
8. NVDA
9. GO
10. ARX

Go back to H.C. Wainwright Reiterates Buy Rating on Halozyme Therapeutics (HALO)
Halozyme Therapeutics, Inc. (NASDAQ: HALO) Delayed: 99.77 -2.02 (1.98%)
Previous Close $101.79    52 Week High $18.39 
Open $101.95    52 Week Low $6.96 
Day High $102.40    P/E N/A 
Day Low $99.41    EPS $-0.58 
Volume 492,339